文献速递类风湿关节炎其他结缔组织病

利用血清学与临床因素构建类风湿关节炎相关间质性肺病进展预测模型:前瞻性KORAIL队列

Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohort.
PubMed 文献 · Semin Arthritis Rheum · 2025-04-17

在韩国类风湿关节炎相关间质性肺病(RA-ILD)前瞻性队列中分析138例患者,中位随访2.9年期间34.8%出现RA-ILD进展。基于普通型间质性肺炎(UIP)型、ILD范围、DLCO%pred和抗CCP滴度(含或不含KL-6)构建的预测模型AUC分别为0.73和0.75,高风险组阳性预测值85.7%,低风险组阴性预测值94.7%。

要点

  • UIP型、ILD范围>10%、较低DLCO%pred、抗CCP、KL-6及表面活性蛋白D与RA-ILD进展相关。
  • 含或不含血清KL-6的预测模型AUC分别为0.73和0.75。
  • 高风险组进展阳性预测值85.7%,低风险组阴性预测值94.7%。

核心结论

  • 在该前瞻性队列中,UIP型、ILD范围、较低DLCO、RA疾病活动度、抗CCP水平及肺损伤生物标志物与RA-ILD进展相关。
  • 作者构建的预测模型在经外部验证后可能有助于临床风险分层。

研究设计与样本

  • 韩国RA-ILD(KORAIL)前瞻性队列研究,纳入符合ACR/EULAR标准且胸部CT显示ILD的RA患者,随访3年。
  • 每年进行肺功能检查(PFT)和胸部CT扫描,分析138例RA-ILD患者(平均年龄66.4岁,男性30.4%,UIP型占60.1%)。

主要发现

  • 中位随访2.9年期间,34.8%(n=48)患者出现RA-ILD进展。
  • 基线时与进展相关的因素包括UIP型、ILD范围>10%、DLCO%pred、抗环瓜氨酸肽(抗CCP)、KL-6和人表面活性蛋白D。
  • 使用UIP型、ILD范围、DLCO%pred和抗CCP滴度构建的模型(含或不含血清KL-6)AUC分别为0.73和0.75。
  • 高风险组对进展的阳性预测值为85.7%,低风险组的阴性预测值为94.7%。

关键数值与推荐

  • RA-ILD进展定义为生理学和影像学均恶化,改编自2023年ATS/ERS/JRS/ALAT进行性肺纤维化定义。

临床怎么用

  • 作者认为所构建的预测模型在经外部验证后可能有助于临床风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop a prediction model for rheumatoid arthritis-associated interstitial lung disease (RA-ILD) progression. METHODS: We investigated predictors of RA-ILD progression in the Korean RA-ILD (KORAIL) cohort, a prospective study that enrolled patients with RA meeting ACR/EULAR criteria and ILD on chest computed tomography (CT) scans and followed for 3 years. Pulmonary function tests (PFTs) and chest CT scans were conducted annually. RA-ILD progression was defined as both physiological and radiological worsening, adapted from the 2023 ATS/ERS/JRS/ALAT definition of progressive pulmonary fibrosis. Baseline factors included clinical factors and biomarkers (autoantibodies, inflammatory markers, and pulmonary damage markers). RESULTS: We analyzed 138 RA-ILD patients (mean age 66.4 years, 30.4 % male, 60.1 % usual interstitial pneumonia [UIP] pattern). During a median follow-up of 2.9 years, 34.8 % (n = 48) had RA-ILD progression. Baseline associations with progression included: UIP pattern, ILD extent >10 %, DLCO %pred., anti-cyclic citrullinated peptide (anti-CCP), Krebs von den Lungen-6 (KL-6), and human surfactant protein D. We developed prediction models using UIP pattern, ILD extent, DLCO % pred., and anti-CCP titer with or without serum KL-6 levels. The models had areas under the curve (AUCs) of 0.73 and 0.75, respectively. The high-risk group had a positive predictive value for progression of 85.7 %, while the low-risk group had a negative predictive value of 94.7 %. CONCLUSION: In this prospective cohort, UIP pattern, ILD extent, lower DLCO, RA disease activity, anti-CCP levels, and pulmonary damage biomarkers were associated with RA-ILD progression. We developed prediction models that may be clinically useful to risk stratify once externally validated.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Chang SH, Paudel ML, McDermott GC, et al. Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohort. Semin Arthritis Rheum. 2025. PMID: 40294559. doi:10.1016/j.semarthrit.2025.152729

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。